4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-22-003274
CFO, EVP & Treasurer sold 47,776 shares at an average $24.75 ($1,182,622)
- CFO, EVP & Treasurer acquired 47,776 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PETERS WILLIAM J CFO, EVP & Treasurer | 2022-01-07 | Option exercise | +31,776 | $14.40 | $457,574 | 137,818 | D |
| PETERS WILLIAM J CFO, EVP & Treasurer | 2022-01-07 | Sale | −20,000 | $24.15 | $483,000 | 117,818 | D |
| PETERS WILLIAM J CFO, EVP & Treasurer | 2022-01-07 | Sale | −11,776 | $24.90 | $293,222 | 106,042 | D |
| PETERS WILLIAM J CFO, EVP & Treasurer | 2022-01-10 | Option exercise | +16,000 | $14.40 | $230,400 | 122,042 | D |
| PETERS WILLIAM J CFO, EVP & Treasurer | 2022-01-10 | Sale | −16,000 | $25.40 | $406,400 | 106,042 | D |
| Derivatives | |||||||
| PETERS WILLIAM J CFO, EVP & Treasurer | 2022-01-07 | Option exercise · Employee Stock Option (right to buy) | −31,776 | 66,777 | D | ||
| PETERS WILLIAM J CFO, EVP & Treasurer | 2022-01-10 | Option exercise · Employee Stock Option (right to buy) | −16,000 | 50,777 | D | ||
| Open-market sales · 47,776 sh · avg $24.75 · $1,182,622 | |||||||
Loading xslF345X03/tm221514-3_4seq1.xml…